ScoreWhy is Heron Therapeutics, Inc. ?
1
The company has declared negative results for the last 3 consecutive quarters
- INTEREST(HY) At USD 8.11 MM has Grown at 64.33%
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.58 times
- RAW MATERIAL COST(Y) Grown by 11.53% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -79.85%, its profits have risen by 38.4%
3
Below par performance in long term as well as near term
- Along with generating -79.85% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Heron Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Heron Therapeutics, Inc.
-79.85%
-1.08
81.64%
S&P 500
20.78%
1.56
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.81%
EBIT Growth (5y)
14.77%
EBIT to Interest (avg)
-77.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-4.45
Sales to Capital Employed (avg)
0.96
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.31
EV to EBIT
-118.63
EV to EBITDA
241.76
EV to Capital Employed
2.23
EV to Sales
1.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.88%
ROE (Latest)
-58.30%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -20.26 MM
-32What is not working for the Company
INTEREST(HY)
At USD 8.11 MM has Grown at 64.33%
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.58 times
RAW MATERIAL COST(Y)
Grown by 11.53% (YoY
CASH AND EQV(HY)
Lowest at USD 91.41 MM
DEBT-EQUITY RATIO
(HY)
Highest at 1,059.98 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.86 times
NET SALES(Q)
Lowest at USD 34.71 MM
OPERATING PROFIT(Q)
Lowest at USD -4.24 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -12.2 %
PRE-TAX PROFIT(Q)
Lowest at USD -8.11 MM
NET PROFIT(Q)
Lowest at USD -8.11 MM
Here's what is working for Heron Therapeutics, Inc.
Operating Cash Flow
Highest at USD -20.26 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Here's what is not working for Heron Therapeutics, Inc.
Pre-Tax Profit
At USD -8.11 MM has Fallen at -288.27%
over average net sales of the previous four periods of USD -2.09 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -8.11 MM has Fallen at -288.27%
over average net sales of the previous four periods of USD -2.09 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 8.11 MM has Grown at 64.33%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 0.58 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
Lowest at USD 34.71 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Net Sales
At USD 34.71 MM has Fallen at -10.37%
over average net sales of the previous four periods of USD 38.73 MMMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit
Lowest at USD -4.24 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -12.2 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD -8.11 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -8.11 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 91.41 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 1,059.98 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 1.86 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 11.53% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
